• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Ticagrelor Companies

    ID: MRFR/Pharma/0324-CR
    101 Pages
    Kinjoll Dey
    July 2019

    Several pharmaceutical companies were involved in the production and distribution of ticagrelor. It's important to note that the status of companies and the pharmaceutical landscape can change.Ticagrelor is an antiplatelet medication commonly used to prevent blood clots in individuals with acute coronary syndromes.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Ticagrelor Market

    Ticagrelor Key Companies

     

    Latest Ticagrelor Companies Update:

    AstraZeneca Partnered with Sun Pharmaceutical Industries Ltd. to distribute Axcer, AstraZeneca's new brand of Ticagrelor, in India. This aims to boost accessibility and usage in a key market. Entered into a collaboration with the International Society for Thrombosis and Haemostasis (ISTH) to develop educational resources and programs for healthcare professionals on the optimal use of Ticagrelor.


    Generic players Several companies like Sun Pharma, Zydus Cadila, Glenmark Pharmaceuticals, and Cipla have launched their generic versions of Ticagrelor in different markets, leading to increased competition and potential price reductions. The generic entry is expected to significantly impact AstraZeneca's market share, particularly in cost-sensitive regions.


    List of Ticagrelor Key companies in the market



    • AstraZeneca

    • Eli Lilly

    • Ingelheim

    • Alexion

    • Roche

    • Amgen

    • Boehringer

    • Pfizer

    • Merck

    • GSK

    • Boehringer

    • Amgen